[Effects of alendronate on the markers of bone metabolic activity in postmenopausal women with osteoporosis]. [electronic resource]
- Medicinski pregled
- 393-9 p. digital
Publication Type: English Abstract; Journal Article
0025-8105
10.2298/mpns0508393i doi
Alendronate--therapeutic use Bone Density Conservation Agents--therapeutic use Bone Remodeling Bone and Bones Female Humans Middle Aged Osteocalcin--blood Osteoporosis, Postmenopausal--drug therapy